Publications

• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells Dorigo, O., Gil, J. S., Gallaher, S. D., Tan, B. T., Castro, M. G., Lowenstein, P. R., … Berk, A. J. (2004). Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. JOURNAL OF VIROLOGY, 78(12), 6556–66.
  
• Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomy. Masghati, S., Nosratian, M., & Dorigo, O. (2014). Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomy. Obstetrics and Gynecology, 123(2), 433–435.
  
• 
  
• Solid pseudopapillary neoplasm, pancreas type, presenting as a primary ovarian neoplasm Stoll, L. M., Parvataneni, R., Johnson, M. W., Gui, D., Dorigo, O., & Sullivan, P. (2012). Solid pseudopapillary neoplasm, pancreas type, presenting as a primary ovarian neoplasm. HUMAN PATHOLOGY, 43(8), 1339–1343.
  
• Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development Sullivan, P. S., Maresh, E. L., Seligson, D. B., Habeeb, O., Wadehra, M., Goodglick, L., & Dorigo, O. (2012). Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development. MODERN PATHOLOGY, 25(8), 1140–1148.
  
• Effect of PI3K/Akt Pathway Inhibition-Mediated G(1) Arrest on Chemosensitization in Ovarian Cancer Cells Fekete, M., Santiskulvong, C., Eng, C., & Dorigo, O. (2012). Effect of PI3K/Akt Pathway Inhibition-Mediated G(1) Arrest on Chemosensitization in Ovarian Cancer Cells. ANTICANCER RESEARCH, 32(2), 445–452.
  
• Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease Karam, A., & Dorigo, O. (2012). Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease. GYNECOLOGIC ONCOLOGY, 125(2), 346–351.
  
• MMPs in Ovarian Cancer as Therapeutic Targets Karam, A., & Dorigo, O. (2012). MMPs in Ovarian Cancer as Therapeutic Targets. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 12(7), 764–772.
  
• Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Penner, K. R., Dorigo, O., Aoyama, C., Ostrzega, N., Balzer, B. L., Rao, J., … Holschneider, C. H. (2012). Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy. GYNECOLOGIC ONCOLOGY, 124(3), 542–548.
  
• Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells Sharma, S., Santiskulvong, C., Bentolila, L. A., Rao, J., Dorigo, O., & Gimzewski, J. K. (2012). Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 8(5), 757–766.
  
• Dual targeting of mammalian target of rapamycin and phosphoinositide 3-kinase using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma Dorigo, O., Santiskulvong, C., Fekete, M., Karam, A., Mulholland, D., Eng, C., & Wu, H. (2009). Dual targeting of mammalian target of rapamycin and phosphoinositide 3-kinase using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma. GYNECOLOGIC ONCOLOGY, 112(2), S9–S10.
  
• Cisplatin and PI3kinase Inhibition Decrease Invasion and Migration of Human Ovarian Carcinoma Cells and Regulate Matrix-Metalloproteinase Expression Karam, A. K., Santiskulvong, C., Fekete, M., Zabih, S., Eng, C., & Dorigo, O. (2010). Cisplatin and PI3kinase Inhibition Decrease Invasion and Migration of Human Ovarian Carcinoma Cells and Regulate Matrix-Metalloproteinase Expression. CYTOSKELETON, 67(8), 535–544.
  
• Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector Gallaher, S. D., Gil, J. S., Dorigo, O., & Berk, A. J. (2009). Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector. JOURNAL OF VIROLOGY, 83(7), 3249–3257.
  
• Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient Lipshutz, G. S., Mihara, N., Wong, R., Wallace, W. D., Allen-Auerbach, M., Dorigo, O., … Pham, P.-T. T. (2009). Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient. AMERICAN JOURNAL OF TRANSPLANTATION, 9(2), 428–432.
  
• Enhanced expression of L9'S mutant alpha 4 nAChR in adult mice increases the loss of midbrain dopaminergic neurons Schwarz, S. C., Dorigo, O., Labarca, C., Berk, A. J., Lester, H. A., & Schwarz, J. (2004). Enhanced expression of L9'S mutant alpha 4 nAChR in adult mice increases the loss of midbrain dopaminergic neurons. Presented at the 8th International Congress of Parkinsons Disease and Movement Disorders, ROME,ITALY: WILEY-LISS.
  
• Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine Shawler, D. L., Bartholomew, R. M., Garrett, M. A., Trauger, R. J., Dorigo, O., Van Beveren, C., … SOBOL, R. E. (2002). Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 129(1), 99–106.
  
• Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function Dorigo, O., Turla, S. T., Lebedeva, S., & Gjerset, R. A. (1998). Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function. JOURNAL OF NEUROSURGERY, 88(3), 535–540.
  
• Progress and prospects in vaccine therapy for gynecologic cancers. Gurski, K. J., & Steller, M. A. (1997). Progress and prospects in vaccine therapy for gynecologic cancers. Oncology (Williston Park, N.Y.), 11(11), 1727-?
  
• Construction and characterization of retroviral vectors for interleukin-2 gene therapy Fakhrai, H., Shawler, D. L., VANBEVEREN, C., Lin, H., Dorigo, O., Solomon, M. J., … SOBOL, R. E. (1997). Construction and characterization of retroviral vectors for interleukin-2 gene therapy. JOURNAL OF IMMUNOTHERAPY, 20(6), 437–448.
  
• Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., MERCOLA, D., Black, K. L., … SOBOL, R. E. (1996). Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 93(7), 2909–2914.
  
• COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA Shawler, D. L., Dorigo, O., Gjerset, R. A., Royston, I., SOBOL, R. E., & Fakhrai, H. (1995). COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA. JOURNAL OF IMMUNOTHERAPY, 17(4), 201–208.
  
• INTERLEUKIN-2 GENE-THERAPY IN A PATIENT WITH GLIOBLASTOMA SOBOL, R. E., Fakhrai, H., Shawler, D., GJERSET, R., Dorigo, O., Carson, C., … Royston, I. (1995). INTERLEUKIN-2 GENE-THERAPY IN A PATIENT WITH GLIOBLASTOMA. GENE THERAPY, 2(2), 164–167.
  
• INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY SOBOL, R. E., Royston, I., Fakhrai, H., Shawler, D. L., Carson, C., Dorigo, O., … Wilson, D. (1995). INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY. HUMAN GENE THERAPY, 6(2), 195–204.
  
• CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSES MUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY Gjerset, R. A., Fakhrai, H., Shawler, D. L., Turla, S., Dorigo, O., GROVERBARDWICK, A., … SOBOL, R. E. (1995). CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSES MUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 31(3), 207–214.
  
• A NON-LYMPHOMA IDIOTYPE IS INDICATIVE AND PREDICTIVE FOR B-CELL MALIGNANCIES IN AIDS Herndier, B., McGrath, M., Abbey, N., Wang, H. T., Ng, V., Dorigo, O., … Kohler, H. (1993). A NON-LYMPHOMA IDIOTYPE IS INDICATIVE AND PREDICTIVE FOR B-CELL MALIGNANCIES IN AIDS. HYBRIDOMA, 12(5), 529–537.
  
• VALUE OF BOWEL RESECTION AND PREOPERATIVE COLOSCOPY IN OVARIAN-CANCER Dorigo, O., Meier, W., Scheidel, P., & Hepp, H. (1993). VALUE OF BOWEL RESECTION AND PREOPERATIVE COLOSCOPY IN OVARIAN-CANCER. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 254(1-4), 966–968.
  
• LYMPHOCYTE SUBPOPULATIONS IN WOMEN WITH MALIGNANT-TUMORS IN CORRELATION WITH KNOWN PROGNOSTIC FACTORS AND AS DISEASE PARAMETERS DURING CYTOKINE THERAPY ROMISCH, M., Bauer, F., Daponte, A., Meier, W., Dorigo, O., & Eiermann, W. (1993). LYMPHOCYTE SUBPOPULATIONS IN WOMEN WITH MALIGNANT-TUMORS IN CORRELATION WITH KNOWN PROGNOSTIC FACTORS AND AS DISEASE PARAMETERS DURING CYTOKINE THERAPY. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 254(1-4), 1091–1093.
  
• ACTIVATION OF NEUTROPHILS IN THE MICROVASCULATURE OF THE ISCHEMIC AND REPERFUSED MYOCARDIUM Tillmanns, H., Neumann, F. J., Tiefenbacher, C., Dorigo, O., Parekh, N., Waas, W., … Kuebler, W. (1993). ACTIVATION OF NEUTROPHILS IN THE MICROVASCULATURE OF THE ISCHEMIC AND REPERFUSED MYOCARDIUM. Presented at the 2nd Symposium of the German-Heart-Institute - Coronary Endothelium and Smooth Muscle : Basic Aspects and Clinical Consequences, BERLIN,GERMANY: W B SAUNDERS CO LTD.
  
• A MONOCLONAL-ANTIBODY (IF7) SPECIFIC FOR HUMAN ANTI-HIV IG INDUCES APOPTOSIS AND INHIBITS CTL ACTIVITY IN CD8+ LYMPHOCYTES FROM HIV-1 INFECTED INDIVIDUALS Muller, S., Collins, H., Brams, P., Wang, H., Dorigo, O., McGrath, M., … Kohler, H. (1993). A MONOCLONAL-ANTIBODY (IF7) SPECIFIC FOR HUMAN ANTI-HIV IG INDUCES APOPTOSIS AND INHIBITS CTL ACTIVITY IN CD8+ LYMPHOCYTES FROM HIV-1 INFECTED INDIVIDUALS. WILEY-BLACKWELL.
  
• NEW TECHNIQUES FOR THE STUDY OF THE CORONARY MICROCIRCULATION - IMPORTANCE OF MEASUREMENTS OF CORONARY FLOW RESERVE IN THE CLINICAL SETTING Tillmanns, H., Neumann, F. J., Waas, W., Mall, G., Parekh, N., Tiefenbacher, C., … Kubler, W. (1992). NEW TECHNIQUES FOR THE STUDY OF THE CORONARY MICROCIRCULATION - IMPORTANCE OF MEASUREMENTS OF CORONARY FLOW RESERVE IN THE CLINICAL SETTING. CORONARY ARTERY DISEASE, 3(7), 586–592.
  
• SHORT-TERM OUTCOME IN INFANTS WITH BIRTH WEIGHTS LESS-THAN 1750-G BORN TO MOTHERS WITH HELLP SYNDROME Gortner, L., Pohlandt, F., Bartmann, P., Terinde, R., Versmold, H., & Dorigo, O. (1992). SHORT-TERM OUTCOME IN INFANTS WITH BIRTH WEIGHTS LESS-THAN 1750-G BORN TO MOTHERS WITH HELLP SYNDROME. JOURNAL OF PERINATAL MEDICINE, 20(1), 25–28.
  
• PHARMACOLOGICAL EFFECTS ON CORONARY MICROVESSELS DURING MYOCARDIAL-ISCHEMIA Tillmanns, H., Neumann, F. J., Parekh, N., Dorigo, O., Tiefenbacher, C., Zimmermann, R., … Kubler, W. (1990). PHARMACOLOGICAL EFFECTS ON CORONARY MICROVESSELS DURING MYOCARDIAL-ISCHEMIA. EUROPEAN HEART JOURNAL, 11, 10–15.
  
• MICROCIRCULATION IN THE HYPERTROPHIC AND ISCHEMIC HEART Tillmanns, H., Neumann, F. J., Parekh, N., Zimmermann, R., Tiefenbacher, C., Dorigo, O., … Kubler, W. (1990). MICROCIRCULATION IN THE HYPERTROPHIC AND ISCHEMIC HEART. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 39, S9–S12.
  
• Apoptosis of CD4+ and CD8+ cells from HIV-1 infected individuals: role of anti-idiotypic antibodies Muller, S., Brams, P., Collins, H., Dorigo, O., & Kohler, H. (1995). Apoptosis of CD4+ and CD8+ cells from HIV-1 infected individuals: role of anti-idiotypic antibodies. Vaccine Research, Vol 4(No 4).
  
• Immuno-gene therapy of colon carcinoma and central nervous tumors Sobol, R. E., Fakhrai, H., Shawler, D. L., Dorigo, O., Gjerset, R. A., Mercola, D., … Bartholomew, R. (1996). Immuno-gene therapy of colon carcinoma and central nervous tumors. In: Gene Therapy and Cancer.
  
• Interleukin-2 (IL-2) gene therapy with allogenic fibroblasts in the CT-26 model of murine colorectal carcinoma Shawler, D. L., Dorigo, O., Van Beveren, C., Bartholomew, R. M., Fakhrai, H., & Sobol, R. E. (1997). Interleukin-2 (IL-2) gene therapy with allogenic fibroblasts in the CT-26 model of murine colorectal carcinoma. Oncology Reports, 4(N1).
  
• Gene therapy for ovarian cancer – Molecular scissors of the new millenium? Dorigo, O., & Berek, J. S. (1998). Gene therapy for ovarian cancer – Molecular scissors of the new millenium? Journal of Gynecologic Techniques, 4.
  
• Synergy of transforming growth factor beta (TGF-beta) antisense and IL-2 gene therapy in the murine ovarian teratoma model Dorigo, O., Shawler, D. L., Royston, I., Sobol, R. E., Berek, J. S., & Fakhrai, H. (1998). Synergy of transforming growth factor beta (TGF-beta) antisense and IL-2 gene therapy in the murine ovarian teratoma model. Gynecologic Oncology, (71).
  
• Enhanced Expression of L9'S Mutant nAChR in Adult Mice Increases the Loss of Midbrain Dopaminergic Neurons Schwarz, J., Schwarz, S. C., Dorigo, O., Labarca, C., Deshpande, P., Gil, J., … Lester, H. A. (2006). Enhanced Expression of L9'S Mutant nAChR in Adult Mice Increases the Loss of Midbrain Dopaminergic Neurons. The Journal of the Federation of American Societies for Experimental Biology, (20 (7).
  
• The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells Sharma, S., Santiskulvong, C., Rao, J., Gimzewski, J. K., & Dorigo, O. (2014). The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells. INTEGRATIVE BIOLOGY, 6(6), 611–17.
  
• Cervical cancer, version 2.2015. Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Cho, K. R., … Scavone, J. L. (2015). Cervical cancer, version 2.2015. Journal of the National Comprehensive Cancer Network , 13(4), 395–404.
  
• 
  
• Uterine Sarcoma, Version 1.2016 Featured Updates to the NCCN Guidelines Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Cho, K. R., … Scavone, J. L. (2015). Uterine Sarcoma, Version 1.2016 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(11), 1321–31.
  
• Screening cell mechanotype by parallel microfiltration Qi, D., Gill, N. K., Santiskulvong, C., Sifuentes, J., Dorigo, O., Rao, J., … Rowat, A. C. (2015). Screening cell mechanotype by parallel microfiltration. SCIENTIFIC REPORTS, 5.
  
• 
  
• Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer Moughon, D. L., He, H., Schokrpur, S., Jiang, Z. K., Yaqoob, M., David, J., … Wu, L. (2015). Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer. CANCER RESEARCH, 75(22), 4742–52.
  
• Screening cell mechanotype by parallel microfiltration. Qi, D., Kaur Gill, N., Santiskulvong, C., Sifuentes, J., Dorigo, O., Rao, J., … Rowat, A. C. (2015). Screening cell mechanotype by parallel microfiltration. Scientific Reports, 5, 17595-?
  
• 
  
• 
  
• Cervical Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Cho, K. R., … Scavone, J. L. (2015). Cervical Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(4), 395–404.
  
• Ovarian Cancer, Version 1.2016 Morgan, R. J., Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Behbakht, K., Chen, L.-may, … Hughes, M. (2016). Ovarian Cancer, Version 1.2016. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(9), 1134–63.
  
• Enhanced expression of hypersensitive alpha 4*nAChR in adult mice increases the loss of midbrain dopaminergic neurons Schwarz, J., Schwarz, S. C., Dorigo, O., Stuetzer, A., Wegner, F., Labarca, C., … Lester, H. A. (2006). Enhanced expression of hypersensitive alpha 4*nAChR in adult mice increases the loss of midbrain dopaminergic neurons. FASEB JOURNAL, 20(7), 935–946.
  
• Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma Santiskulvong, C., Konecny, G. E., Fekete, M., Chen, K.-Y. M., Karam, A., Mulholland, D., … Dorigo, O. (2011). Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma. CLINICAL CANCER RESEARCH, 17(8), 2373–2384.
  
• Interleukin-2 (IL-2) gene therapy with allogeneic fibroblasts in the CT-26 model of murine colorectal carcinoma Shawler, D. L., Dorigo, O., VANBEVEREN, C., Bartholomew, R. M., Fakhrai, H., & SOBOL, R. E. (1997). Interleukin-2 (IL-2) gene therapy with allogeneic fibroblasts in the CT-26 model of murine colorectal carcinoma. ONCOLOGY REPORTS, 4(1), 135–138.
  
• 
  
• 
  
• Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Campos, S. M., Cho, K. R., Chon, H. S., … Scavone, J. (2017). Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 15(1), 92–120.
  
• Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Morgan, R. J., Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Behbakht, K., Chen, L.-may, … Hughes, M. (2016). Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network , 14(9), 1134–1163.
  
• 
  
• 
  
• 
  
• 
  
• Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology Koh, W.-J., Abu-Rustum, N. R., Bean, S., Bradley, K., Campos, S. M., Cho, K. R., … Scavone, J. L. (2018). Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(2), 170–99.
  
• 
  
• Hypoxic signaling in the tumor-mesothelial niche promotes collagen remodeling and ovarian cancer metastasis. Foreman, K., Fuh, K., SorianoJAL, M., Dorigo, O., Krishnan, V., Shehade, H., … Rankin, E. (2018). Hypoxic signaling in the tumor-mesothelial niche promotes collagen remodeling and ovarian cancer metastasis. CLINICAL CANCER RESEARCH, 24(15), 57.
  
• 
  
• Single cell analysis of ascites macrophages in ovarian cancer He, H. M., Yu, F. B., Quake, S. R., & Dorigo, O. (2015). Single cell analysis of ascites macrophages in ovarian cancer. CANCER RESEARCH, 75.
  
• Parallel microfiltration (PMF): A novel method to screen cell mechanotype Wiedemeyer, W.-R., Qi, D., Gi, N. K., Santiskulvong, C., Dorigo, O., Rao, J. Y., … Rowat, A. C. (2015). Parallel microfiltration (PMF): A novel method to screen cell mechanotype. CANCER RESEARCH, 75.
  
• Comprehensive genomic profiling (CGP) of cervical squamous cell carcinoma (cSCC) to identifiy targeted therapy options. Elvin, J. A., Bailey, M., Carneiro, B. A., Ali, S. M., Vergilio, J.-A., Palma, N. A., … Dorigo, O. (2015). Comprehensive genomic profiling (CGP) of cervical squamous cell carcinoma (cSCC) to identifiy targeted therapy options. JOURNAL OF CLINICAL ONCOLOGY, 33(15).
  
• M2 macrophage inhibition reverses vascular leaks that cause malignant ascites in late-stage epithelial ovarian cancer Moughon, D., He, H., Schokrpur, S., Jiang, Z., Yaqoob, M., David, J., … Wu, L. (2015). M2 macrophage inhibition reverses vascular leaks that cause malignant ascites in late-stage epithelial ovarian cancer. CANCER RESEARCH, 75(1).
  
• Mutational analysis of serous ovarian cancer using Ion Torrent sequencing Masghati, S., Dorigo, O., & Santisvkulvong, C. (2014). Mutational analysis of serous ovarian cancer using Ion Torrent sequencing. CANCER RESEARCH, 74(19).
  
• The role of tumor associated macrophages in ovarian cancer He, H., Moughon, D. L., Hillerup, C., ElMasri, W., Wu, L., & Dorigo, O. (2014). The role of tumor associated macrophages in ovarian cancer. GYNECOLOGIC ONCOLOGY, 135(2), 385.
  
• 
  
• 
  
• 
  
• Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis. Natarajan, S., Foreman, K. M., Soriano, M. I., Rossen, N. S., Shehade, H., Fregoso, D. R., … Rankin, E. B. (2019). Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis. Cancer Research.
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
•